Health and Welfare Minister Chen Shih-chung (陳時中) said Thursday that the Taiwan government has asked the American drugmaker Gilead Sciences to reserve doses of its experimental drug Remdesivir for potential use in Taiwan, amid reports that the antiviral medication may be effective in treating the novel coronavirus (2019-nCoV).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Analyst warns Air Force may be losing more pilots to early retirement
09/04/2026 08:14 PM - Business
Taichung power plant hits gas milestone on path to 2034 coal-free goal
09/04/2026 07:35 PM - Society
Heavy rain triggers 41 incidents across Taipei
09/04/2026 06:14 PM - Politics
Domestic needs to drive next Trump-Xi meeting: Scholar
09/04/2026 06:00 PM - Society